GA&P Team: Richard Silberstein (partner), Alex Carbonell (partner), José Francisco Canalejas-Finance (associate), Elisabet Rojano (associate) and José Angel Cano (partner)

Acquirer: Altan Pharma Limited

Country: Ireland

Target: The GES Group

Country: Spain

Value: €87.5m

Deal description: Altan Pharma Limited has acquired a privately held group of Spanish companies, The GES Group, which develops, manufactures, and markets specialty injectable drugs, for a total consideration of EUR 87.5m. GES Group is comprised of three operating companies namely, GES Genericos Espanoles Laboratorio, S.A.U, Genfarma Laboratorio, S.L., and Biomendi, S.A.U.